Bluejay Diagnostics (BJDX) Non-Current Debt (2021)
Bluejay Diagnostics (BJDX) posted Non-Current Debt of $10000.0 for Q4 2021, little changed sequentially from $10000.0 in Q3 2021.
Bluejay Diagnostics (BJDX) Non-Current Debt (2021) Analysis & Trends
Bluejay Diagnostics has reported Non-Current Debt for 1 years, with the latest figure at $10000.0 in Q4 2021.
- Quarterly Non-Current Debt changed N/A year-over-year to $10000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $10000.0 (changed N/A YoY) and the FY2021 annual result came in at $10000.0, changed N/A from the prior year.
- Non-Current Debt was little changed at $10000.0 in Q4 2021 per BJDX's latest filing, from $10000.0 in the prior quarter.
- Over five years, Non-Current Debt peaked at $10000.0 in Q3 2021 and troughed at $10000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Bluejay Diagnostics | 1.91 Mn | 1.91 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 10,000.00 |
| Sep 30, 2021 | 10,000.00 |